Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies in New Jersey
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in New Jersey
| Provider | Medicare | Services |
|---|---|---|
| Laboratory Corporation Of America... | $23.56 | 10.3K |
| Quest Diagnostics Incorporated | $23.59 | 8.2K |
| Bioreference Health, Llc | $23.58 | 6.2K |
| Accu Reference Medical Lab, Llc | $23.60 | 1.5K |
| Synergy Medical Laboratories Inc | $23.60 | 125 |
| Lincoln Diagnostics Llc | $23.60 | 94 |
| Fusion Diagnostics Laboratories | $23.60 | 86 |
| Spectra East, Inc. | $23.60 | 76 |
| Aculabs Inc | $23.60 | 71 |
| Rnj Services, Inc | $23.60 | 62 |
New Jersey Pricing in Context
In New Jersey, CPT code 87389 (Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies) carries an average Medicare payment of $23.57 — 0% above the national benchmark of $23.55. 119 providers across the state submitted claims for this procedure in 2023, performing 27.1K total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in New Jersey is $127.54, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in New Jersey lands near $60.11, with self-pay cash prices typically around $52.75. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies cost in New Jersey?
The average Medicare payment for Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies in New Jersey is $23.57, which is 0% above the national average of $23.55. Providers in NJ typically bill $127.54 for this procedure.
What does Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies cost with insurance in New Jersey?
With commercial insurance in New Jersey, Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies costs an estimated $60.11. Without insurance, the estimated cash price is $52.75. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies in New Jersey?
119 providers in New Jersey billed Medicare for Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies in 2023, performing 27.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies cheaper in New Jersey than the national average?
No — Detection Test By Immunoassay Technique For Hiv-1 Antigen And Hiv-1 And Hiv-2 Antibodies costs 0% above the national average in New Jersey. The state average Medicare payment is $23.57 compared to $23.55 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.